|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
This working group seeks to develop guidelines for best practices for Next Generation Sequencing to identify viral contaminants in biological products.
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA
|
NIDDK, NIEHS
|
This initiative aims to improve the lives of Americans suffering from kidney disease, expand options for American patients, and reduce healthcare costs. The initiative provides specific solutions to deliver on three goals: fewer patients developing kidney failure, fewer Americans receiving dialysis in dialysis centers, and more kidneys available for transplant.
|
|
Advancing Early Psychosis Care in the United States: Innovations from the Field
|
Meeting/ Workshop
|
SAMHSA
|
NIMH
|
With the rapid expansion of evidence-based early psychosis care in the U.S., largely the result of the successful NIMH-funded Recovery After an Initial Schizophrenia Episode (RAISE) initiative, additional clinician training on early psychosis is needed. The National Institute of Mental Health (NIMH), in collaboration with the Substance Abuse and Mental Health Services Administration (SAMHSA), sponsored a meeting entitled, "Advancing Early Psychosis Care in the United States: Innovations from the Field," on October 7, 2018. The meeting was held as a pre-conference event in conjunction with the International Early Psychosis Association''s biannual meeting in Boston. More than 300 clinicians and other professionals working in the early psychosis care field attended the event. NIMH staff served on the planning committee and as presenters.
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
CC, NHLBI
|
The Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) is a 31-member federal advisory committee that provides advice to the Secretary of Health and Human Services through the Assistant Secretary for Health on a range of policy issues related to blood, blood products, and tissues.
|
|
Advisory Committee on Heritable Disorders in Newborn and Children
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA
|
NICHD, NHGRI, NHLBI, NIDDK, NLM
|
The Advisory Committee on Heritable Disorders in Newborns and Children was established under the Public Health Service Act, Title XI, § 1109 (42 USC 300b-10), as amended by the Newborn Screening Saves Lives Reauthorization Act of 2014 (PL 113-240). The mission of the Advisory Committee on Heritable Disorders in Newborns and Children is to reduce morbidity and mortality in newborns and children who have or are at risk for heritable disorders. The Committee recommends that every newborn screening program include a Uniform Screening Panel that screens for 32 core disorders and 26 secondary disorders. The Committee advises the Secretary, US Department of Health and Human Services on the most appropriate application of universal newborn screening tests, technologies, policies, guidelines, and standards. Specifically, the committee provides to the Secretary, the following: Advice and recommendations concerning grants and projects authorized, awarded, or funded related to screening heritable disorders in newborns and children; technical information to develop Heritable Disorders Program policies and priorities that will enhance the ability of the state and local health agencies to provide screening; counseling and health care services for newborns and children who have or are at risk for heritable disorders, and recommendations; and advice and information to enhance, expand, or improve the ability of the Secretary to reduce mortality and morbidity from heritable disorders in newborns and children. The committee was chartered on May 7, 2015.
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NIAID
|
The Advisory Committee on Organ Transplantation (ACOT) was established to assist the Department of Health and Human Services (HHS) Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, thereby increasing public confidence in the integrity and effectiveness of the transplantation system.
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
The Advisory Council advises the Secretary, Department of Health and Human Services and Administrator, Health Resources and Services Administration (HRSA) on matters related to the activities of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory Program. The principal purpose of these programs is to make blood stem cells from adult donors and cord blood units available for patients who need a transplant to treat life-threatening conditions such as leukemia, and who lack a suitably matched relative who can be the donor.
|
|
Agricultural Health Study
|
Research Initiative
|
CDC
|
NCI, NIEHS
|
The Agricultural Health Study (AHS) is a collaborative effort involving investigators from National Cancer Institute, the National Institute of Environmental Health Sciences, the Environmental Protection Agency, and the National Institute for Occupational Safety and Health. The study is a prospective study of cancer and other health outcomes in a cohort of licensed pesticide applicators and their spouses from Iowa and North Carolina. The AHS began in 1993 with the goal of answering important questions about how agricultural, lifestyle and genetic factors affect the health of farming populations. More than 89,000 farmers and their spouses in Iowa and North Carolina have participated in the study. Their participation has provided and continues to provide the data that researchers need to help the current and future generations of farmers and their families live healthier lives.
|
|
AHRQ Registry of Patient Registries (RoPR)
|
Resource Development
|
AHRQ
|
NLM
|
The Registry of Patient Registries (RoPR) is a database of registry-specific information intended to promote collaboration, reduce redundancy, and improve transparency. ClinicalTrials.gov worked with RoPR to implement a mechanism for patient registries to be registered in ClinicalTrials.gov and additional information provided directly at RoPR. This collaboration ended in April 2019 after RoPR was discontinued.
|
|
AIDSinfo/InfoSIDA
|
Public Education Campaign
|
CDC, FDA, HRSA
|
NLM, NIAID, OD/DPCPSI/OAR
|
AIDSinfo, a service of the US Department of Health and Human Services (HHS), offers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and the general public.
|